FLUARIXTETRA, tetravalent vaccine against seasonal influenza
INFECTIOLOGY - NEW MEDICINAL PRODUCT
Opinions on drugs -
Posted on
Sep 10 2015
Reason for request
Inclusion
» FLUARIXTETRA is an inactivated, split-virion, injectable vaccine with Marketing Authorisation in the active immunisation of adults and children aged 3 years and upwards for the prevention of influenza caused by the two influenza A virus subtypes and the two influenza B virus types contained in the vaccine.
» This is the first injectable vaccine containing four influenza vaccine strains. It differs from trivalent influenza vaccines by the addition of a second type B strain.
» The impact of the addition of a second virus B strain is not expected in terms of public health.
Clinical Benefit
Substantial |
- |
Clinical Added Value
no clinical added value |
- |
Therapeutic use
- |
-
English version
Contact Us
Évaluation des médicaments